Allspring Global Investments Holdings LLC 提振了HCA Healthcare,

Allspring Global Investments Holdings LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA – Get Rating) by 47.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 61,489 shares of the company's stock after acquiring an additional 19,855 shares during the period. Allspring Global Investments Holdings LLC's holdings in HCA Healthcare were worth $14,755,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Fidelis Capital Partners LLC bought a new position in HCA Healthcare in the fourth quarter worth about $259,000. Diligent Investors LLC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $207,000. Veriti Management LLC raised its holdings in shares of HCA Healthcare by 88.3% during the fourth quarter. Veriti Management LLC now owns 2,471 shares of the company's stock valued at $593,000 after buying an additional 1,159 shares during the last quarter. Hedeker Wealth LLC raised its holdings in shares of HCA Healthcare by 3.7% during the fourth quarter. Hedeker Wealth LLC now owns 9,453 shares of the company's stock valued at $2,269,000 after buying an additional 341 shares during the last quarter. Finally, Redwood Investments LLC raised its holdings in shares of HCA Healthcare by 1.8% during the fourth quarter. Redwood Investments LLC now owns 4,486 shares of the company's stock valued at $1,076,000 after buying an additional 79 shares during the last quarter. Institutional investors own 64.60% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Cowen lifted their price target on HCA Healthcare from $238.00 to $292.00 and gave the company an "outperform" rating in a report on Monday, January 30th. JPMorgan Chase & Co. boosted their target price on HCA Healthcare from $235.00 to $257.00 and gave the stock an "overweight" rating in a report on Thursday, February 23rd. UBS Group boosted their target price on HCA Healthcare from $237.00 to $296.00 and gave the stock a "buy" rating in a report on Friday, January 13th. Deutsche Bank Aktiengesellschaft boosted their target price on HCA Healthcare from $240.00 to $275.00 in a report on Tuesday, January 3rd. Finally, SVB Leerink boosted their target price on HCA Healthcare from $238.00 to $286.00 and gave the stock an "outperform" rating in a report on Friday, December 16th. One research analyst has rated the stock with a sell rating, one has given a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $269.41.

HCA Healthcare Stock Performance

NYSE HCA opened at $270.59 on Friday. HCA Healthcare, Inc. has a twelve month low of $164.47 and a twelve month high of $279.02. The stock has a market cap of $75.02 billion, a price-to-earnings ratio of 14.07, a PEG ratio of 1.89 and a beta of 1.64. The firm's 50 day moving average price is $255.26 and its two-hundred day moving average price is $236.80.

HCA Healthcare (NYSE:HCA – Get Rating) last posted its quarterly earnings results on Friday, January 27th. The company reported $4.64 EPS for the quarter, missing the consensus estimate of $4.79 by ($0.15). HCA Healthcare had a net margin of 9.37% and a negative return on equity of 1,260.96%. The company had revenue of $15.50 billion for the quarter, compared to analysts' expectations of $15.51 billion. On average, research analysts forecast that HCA Healthcare, Inc. will post 17.17 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 31st. Stockholders of record on Friday, March 17th were issued a dividend of $0.60 per share. This is a boost from HCA Healthcare's previous quarterly dividend of $0.56. This represents a $2.40 annualized dividend and a dividend yield of 0.89%. The ex-dividend date was Thursday, March 16th. HCA Healthcare's payout ratio is currently 12.48%.

HCA Healthcare declared that its board has authorized a share buyback program on Friday, January 27th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the company to buy up to 4.2% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

Insider Activity

In related news, SVP P. Martin Paslick sold 3,034 shares of HCA Healthcare stock in a transaction on Tuesday, April 4th. The shares were sold at an average price of $265.00, for a total value of $804,010.00. Following the completion of the sale, the senior vice president now owns 24,643 shares of the company's stock, valued at approximately $6,530,395. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, SVP P. Martin Paslick sold 3,034 shares of HCA Healthcare stock in a transaction on Tuesday, April 4th. The shares were sold at an average price of $265.00, for a total value of $804,010.00. Following the completion of the sale, the senior vice president now owns 24,643 shares of the company's stock, valued at approximately $6,530,395. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Christopher F. Wyatt sold 4,900 shares of HCA Healthcare stock in a transaction on Wednesday, February 1st. The shares were sold at an average price of $253.30, for a total transaction of $1,241,170.00. Following the completion of the sale, the senior vice president now directly owns 32,392 shares of the company's stock, valued at approximately $8,204,893.60. The disclosure for this sale can be found here. Insiders have sold a total of 82,933 shares of company stock worth $21,264,504 in the last ninety days. Corporate insiders own 1.60% of the company's stock.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities.

See Also

• Get a free copy of the StockNews.com research report on HCA Healthcare (HCA)
• Hypercharge Networks: Up Triple Digits, But What's The Big Deal?
• 3 Reasons Why Apple's 30% Rally Has Legs
• 3 Reasons to Pick First Citizens Instead of First Republic Bank
• 3 April Earnings Plays for Bullish Swing Traders
• Is Constellation Brands Star About To Rise?

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.